drugset / Press release
Material Information - Argentina ANMAT has Approved the Marketing Authorization Application of BESREMi (Ropeginterferon alfa-2b) for PV
2025-06-18 · PharmaEssentia · original pharmaessentia.com ↗
Download Material Information - Argentina ANMAT has Approved the Marketing Authorization Application of BESREMi (Ropeginterferon alfa-2b) for PV Previous Next
The release as fetched from its publisher. pharmaessentia.com ↗